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Handicap-Recover Evolution Leads to a Chemically
Versatile, Nucleophile-Permissive Protease
Thomas Shafee,[a, b, c] Pietro Gatti-Lafranconi,[a] Ralph Minter,[b] and Florian Hollfelder*[a]
Mutation of the tobacco etch virus (TEV) protease nucleophile
from cysteine to serine causes an approximately ~104-fold loss
in activity. Ten rounds of directed evolution of the mutant,
TEVSer, overcame the detrimental effects of nucleophile ex-
change to recover near-wild-type activity in the mutant
TEVSerX. Rather than respecialising TEV to the new nucleophile,
all the enzymes along the evolutionary trajectory also retained
the ability to use the original cysteine nucleophile. Therefore
the adaptive evolution of TEVSer is paralleled by a neutral tra-
jectory for TEVCys, in which mutations that increase serine nu-
cleophile reactivity hardly affect the reactivity of cysteine. This
apparent nucleophile permissiveness explains how nucleophile
switches can occur in the phylogeny of the chymotrypsin-like
protease PA superfamily. Despite the changed key component
of their chemical mechanisms, the evolved variants TEVSerX and
TEVCysX have similar activities ; this could potentially facilitate
escape from adaptive conflict to enable active-site evolution.
Enzymes achieve efficient catalysis through the precise orienta-
tion of a key set of active-site residues. This arrangement is
dependent on chemical constraints, to the extent that some
active-site geometries have convergently evolved many
times.[1] Consequently, active-site residues are the most evolu-
tionarily conserved within enzyme families. Phylogenetic analy-
sis of extended protein superfamilies suggests that even resi-
dues that are crucial for activity are exchanged during evolu-
tion over sufficiently long timescales.[2] The evidence for such
exchanges raises the question of how a gene coding for an
inefficient enzyme can persevere in the transition from one
type of active site to another. There is no evolutionary advant-
age for maintaining a gene coding for a catalytically impaired
or inactive protein, thus creating the scenario of “adaptive
conflict”.[3] We know from studies on enzymes[4] and enzyme
models[5] that precise positioning is easily disturbed. Minute
disturbances down to the picometer scale cause substantial
rate reductions.[6] Given the delicacy of catalytic arrangements,
it is unknown how the evolution of active sites avoids unfit
variants.
Serine and cysteine proteases are textbook examples of en-
zymes employing covalent, nucleophilic catalysis (Figure 1A)[7]
that leads to substantial rate acceleration of a difficult reaction
(with a half-life of 500 years).[8] The sophisticated interplay of
the multiple active-site residues involved, including for exam-
ple, the charge relay system of the catalytic triad,[7c] suggests
that any deviation from such a highly efficient arrangement is
likely to be penalised.[9] However, phylogenetic analysis of pro-
teases suggests that nucleophile exchanges do occur during
evolution. The PA clan of chymotrypsin-like proteases[10] en-
compasses both serine and cysteine proteases evolved from a
hypothetical common ancestor.[11] Constructing a phylogeny of
this clan of proteases (Figure 1B) shows that—within a highly
conserved structure—nucleophile switches must have oc-
curred by divergent evolution at least once: cellular proteases
use a serine nucleophile, but both cysteine and serine protease
families are found in viruses.[12]
When the active-site nucleophiles of serine or cysteine pro-
tease are interconverted, the single atomic change typically
leads to a >104-fold reduction in kcat/KM.
[9a,14] Although both
thiol and hydroxy groups can act as nucleophilic catalysts,
their positioning is likely to be suboptimal after mutation due
to structural differences between oxygen and sulfur: oxygen’s
smaller atomic radius (by ~0.4 æ)[14a] and the formation of
shorter bonds (decreasing dC–X and dX–H by ~1.3-fold each)
would be expected to disturb the precise nucleophile position-
ing. In addition there are reactivity differences: sulfur is softer,
and its different pKa (4–5 units lower for RSH compared to
ROH) provides a larger fraction of the active form of the nucle-
ophile at physiological pH; this explains why the reactivity of
the hydroxy side chain of serine that replaces cysteine would
be compromised.[14d]
These considerations of chemical reactivity and structure
raise the question of how such nucleophile transitions have oc-
curred in proteases, despite the enzyme inactivation typically
associated with mutating a key active-site residue. Handicap-
recover experiments can be used to find if any mutations can
epistatically offset a known deleterious mutation or the re-
placement of a native cofactor.[15] Here we use this approach
to demonstrate a scenario that could satisfy the fitness require-
ments of protein evolution by mutating the crucial nucleophile
of tobacco etch virus cysteine protease (TEVCys) to serine
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(TEVSer), recovering activity by directed evolution (DE) and
measuring trade-offs in response to nucleophile switches.
The nucleophile mutation compromised the centrepiece of
the catalytic mechanism and consequently had a much greater
effect on activity than in previous handicap-recover experi-
ments.[15] A TEVSer mutant (C151S mutation) was constructed,
and the substitution of the cysteine thiol nucleophile by a
serine alcohol was found to reduce activity by four orders of
magnitude (Figure 2 and Figure S4 in the Supporting Informa-
tion). The effect of this deliberately introduced handicap was
then quantified by measuring the reaction kinetics (by moni-
toring the hydrolysis of the C-Y FRET-pair substrate,[16] Fig-
ure S2). Conversion of the catalytic nucleophile from sulfur to
oxygen resulted in biphasic kinetics (Figures 2A and S3,
Table S2); this is consistent with the formation and breakdown
of an acyl–enzyme intermediate (i.e. , a fast first step followed
by a slower, rate-limiting step, Figure S5). The second-order
rate constants kobs12 and k
obs2
2 of TEV
Ser were found to be 80 and
20000 times lower, respectively, than the measured second-
order rate constant of TEVCys (representing kcat/KM).
In order to investigate how the enzyme can compensate for
the handicap of using a non-native nucleophile and altered re-
action chemistry, ten rounds of DE for activity recovery were
performed (numbered TEVSer to TEVSerX). Each round of DE con-
sisted of error-prone PCR (1.30.4 amino acid mutations per
gene), activity screening of 350 enzyme variants by destruction
of FRET in cell lysate (Figure S2), and selection of the single
best variant. Any S151C revertants were discarded to force
evolution to follow a forward pathway. Measurement of turn-
over rates in cells during screening reflects enzyme fitness as
the product of both chemical reactivity and catalyst concentra-
tion (determined by biophysical properties, such as folding
and solubility). The same FRET-pair substrate was used for
both in vivo screening and in vitro kinetics to describe the
enzyme–substrate interactions that were relevant for the selec-
tion (and avoid unique effects of the recognition of for exam-
ple, small-peptide substrates with different reactivity and affini-
ty).
During the rounds of evolution, no mutations in residues
that make direct contacts with the triad (or are within a radius
of 4 æ) resulted from experimental selections. Conversely, nine
of the 13 point mutations accumulated 4–8 æ from the catalyt-
ic triad, in the second shell of residue interactions (Figure 3). In
vitro kinetics of purified variants showed that the process of di-
rected evolution recovered proteolytic activity by an improve-
ment in both kobs12 (2Õ10
3-fold) and kobs22 (3Õ10
3-fold) and also
changed the burst amplitude (Figure 2A, Tables S2 and S3),
with diminishing improvements in later rounds. The accumula-
tion of mutations around the enzyme active site (second shell)
that increased catalysis reduced soluble expression sixfold;
however, in rounds V and VI, surface mutations (W130C and
E194D) and a C-terminal truncation (due to a frameshift) were
selected that improved both solubility and activity (Figure 2C).
In addition to the adaptive trajectory of TEVSer (Figure 2B,
front), the identified adaptive mutations were examined in the
parental background, by reverting the nucleophile to the origi-
nal cysteine at each step of the evolutionary trajectory (Fig-
ure 2B, back). The kinetics of these TEVCys variants could be
fitted to a monophasic model with good correlation coeffi-
cients. Rather than respecialising the active site to use serine,
as is typical of directed-evolution experiments, the 14 muta-
tions accumulated by DE proved nearly neutral to activity with
Figure 1. A) Simplified catalytic mechanism of cysteine and serine proteases (Nu=S, e.g. , in TEVCys ; or Nu=O, e.g. , in TEVSer).[7] In the enzyme’s catalytic triad
(black) aspartate aligns and polarises histidine, which reduces the nucleophile’s pKa and positions it for reaction. The activated nucleophile attacks the carbon-
yl of the peptide bond of the substrate (red), a tetrahedral intermediate is stabilised by backbone amide hydrogens (“oxyanion hole”), and the C terminus of
the substrate is ejected, leaving a covalent adduct behind. This acyl–enzyme intermediate (lower panel) is hydrolysed by histidine-activated water to release
the N terminus of the substrate (aided by proton transfer to histidine), and this regenerates the free enzyme. B) The phylogeny of the PA clan (MEROPS clas-
sification)[11] of proteases with nucleophile and possible nucleophile-switching events indicated. Proteases with known structures were aligned to TEVCys by
structural comparison using DALI,[13] sequences of unknown structure were added by sequence alignment with BLASTp (see Table S1 and Figure S1 for de-
tails).
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the original cysteine nucleophile (i.e. , did not trade-off). Where-
as the kobs12 and k
obs2
2 of TEV
SerX are 1000-fold improved over
those of TEVSer, the nucleophile revertants retained activity
within fourfold of TEVCys (Figures 2B and S6). The evolutionary
trajectory therefore results in twin enzymes, differing only in
their nucleophile (TEVSerX$TEVCysX) and with only a small, 2.3-
fold difference in activity upon nucleophile exchange.
By forcing TEV into a local fitness valley (TEVSer) and experi-
mentally evolving for activity recovery, we mapped out an
uphill trajectory (TEVSer!TEVSerX) that lies parallel in sequence
space to a nearly flat, neutral trajectory of mutants with con-
stant Cys nucleophile (TEVCys!TEVCysX; Figure 2B). Therefore,
despite deliberately evolving TEVCys by using a fitness valley,
the nucleophile-permissive TEVSerX can also be accessed from
TEVCys by nearly neutral mutations without any large drops in
activity. The most closely related natural serine protease only
retains 15% sequence identity to TEVCys. However, the mutant
TEVSerX shows 92.4% identity (Table S2, Figure 3), thus suggest-
ing that only a few mutations are necessary to accommodate
a nucleophile switch. The >1000-fold improvement to gener-
ate a nucleophile generalist with only 13 mutations explains
how divergent evolution of core catalytic machinery can occur
within evolutionarily superfamilies such as the PA clan (Fig-
ure 1B). It also emphasises the power of directed evolution to
find solutions for the challenge of retuning chemical reactivi-
ty.[17]
The challenge of nucleophile permissiveness is conceptually
similar to that of catalytic promiscuity (the ability of an
enzyme to accept different substrates): how can an enzyme
make and break bonds different from those it has evolved
for?[18] The evolution of promiscuous activities has been previ-
ously observed to pass through catalytic generalists, which
were able to promote a new reaction, while retaining some ac-
tivity on their original substrate. Generalist enzymes are pro-
posed to perform an important role in the evolution of new
functions by being particularly evolvable.[19] Although enzyme
promiscuity towards different substrates is well document-
ed,[18,20] the ability to use different residues for nucleophilic, co-
valent catalysis represents an alternative kind of chemical ver-
satility in the core catalytic machinery.[21]
Figure 2. Activity recovery of the directed evolution lineage from TEVSer to
TEVSerX and the corresponding nucleophile revertants, in which the original
Cys nucleophile was restored. A) Kinetic traces of enzyme activity for the
wild type-type enzyme (TEVCys), the nucleophile mutant (TEVSer), the evolved
enzyme from the tenth round (TEVSerX) and the evolved mutant with a re-
verted nucleophile (TEVCysX). Conditions: [E]=1 mm, [S]=1 mm, pH 8, 25 8C.
B) Development of the activity of purified TEV mutants as a function of the
rounds of directed evolution. Activities are plotted as the second order rate
constants kobs22 of the ten TEV
Ser variants and kcat/KM of the ten TEV
Cys nucleo-
phile revertants. Solid arrows indicate the DE route (starting with the delete-
rious TEVCys!TEVSer mutation, then activity recovery in ten rounds from
TEVSer to TEVSerX) to arrive at the neutral twin enzymes TEVSerX and TEVCysX,
capable of using either nucleophile. The dotted arrow indicates an alterna-
tive, nearly neutral TEVCys!TEVCysX route. Conditions: [E]=1–8 mm, [S]=
1 mm, pH 8, 25 8C. Standard deviations of four repeats were below 15% (Fig-
ure S5). C) Soluble expression of evolved variants and TEVCys back-mutants.
Error bars represent standard deviation of two biological repeats.
Figure 3. Positions of mutations accumulated during directed evolution
mapped onto the structure of TEV protease (PDB ID:1LVM). The catalytic
triad is shown in red, the substrate peptide is in black. There are no muta-
tions within 4 æ of the catalytic triad (the first shell), mutations 4–8 æ from
the triad (the second shell) are shown in dark blue, and mutations 8–12 æ
from the triad (the third shell) are shown in light blue. Mutations in the
second shell around the catalytic triad are enriched compared to what
would be expected from a random distribution.
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Even though the lynchpin of catalysis in the protease active
site—the nucleophile—was mutated, the large activity drop
was readily recoverable by evolution. Quantitatively, both the
handicap introduced and the extent of the recovery exceed
those previously observed by approximately two orders of
magnitude.[15] Specifically, a 120-fold reduction triggered by co-
factor exchange was followed by a 70-fold recovery in a study
by Miller et al.[15a] and a 400-fold reduction caused by mutation
of a conserved residue was followed by a 40-fold recovery ob-
served by Wellner et al. ,[15b] compared with a 20000-fold reduc-
tion and 3000-fold recovery in this work.
What is more, the similar rates of TEVCysX and TEVSerX (3Õ103
vs. 7Õ103 min¢1m¢1) represent a rare example of catalytic pro-
miscuity at high, wild-type levels (in contrast to promiscuous,
yet low-activity catalytic generalists).[22] Paradoxically, a nucleo-
phile mutation would be predicted to be more difficult to re-
cover from, when compared to evolution to accommodate
promiscuous binding of multiple substrates, as two different
types of bonds (O¢C vs. S¢C) are being formed and cleaved.
However, our data suggest that the differences in nucleophile
reactivity and structure can be readily accommodated by TEV
protease with apparently little trade-off between rates for
different nucleophiles. The unexpected nucleophile tolerance
suggests that chemically versatile intermediates such as
TEVSer/CysX exist that could facilitate the phylogenetically ob-
served switch between protease clans that differ in their nucle-
ophiles prior to specialisation. The protein framework of
TEVSer/CysX allows two nucleophiles to execute their function
with good efficiency and constitutes a molecular solution to
escape from adaptive conflict.
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